Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Stem Cell Reports ; 10(2): 390-405, 2018 02 13.
Artículo en Inglés | MEDLINE | ID: mdl-29337120

RESUMEN

Cellular replacement therapies for neurological conditions use human embryonic stem cell (hESC)- or induced pluripotent stem cell (hiPSC)-derived neurons to replace damaged or diseased populations of neurons. For the spinal cord, significant progress has been made generating the in-vitro-derived motor neurons required to restore coordinated movement. However, there is as yet no protocol to generate in-vitro-derived sensory interneurons (INs), which permit perception of the environment. Here, we report on the development of a directed differentiation protocol to derive sensory INs for both hESCs and hiPSCs. Two developmentally relevant factors, retinoic acid in combination with bone morphogenetic protein 4, can be used to generate three classes of sensory INs: the proprioceptive dI1s, the dI2s, and mechanosensory dI3s. Critical to this protocol is the competence state of the neural progenitors, which changes over time. This protocol will facilitate developing cellular replacement therapies to reestablish sensory connections in injured patients.


Asunto(s)
Células Madre Embrionarias Humanas/citología , Células Madre Pluripotentes Inducidas/trasplante , Células Receptoras Sensoriales/citología , Médula Espinal/crecimiento & desarrollo , Proteína Morfogenética Ósea 4/farmacología , Técnicas de Cultivo de Célula , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/genética , Células Madre Embrionarias Humanas/trasplante , Humanos , Células Madre Pluripotentes Inducidas/citología , Interneuronas/citología , Interneuronas/trasplante , Células Receptoras Sensoriales/trasplante , Médula Espinal/fisiopatología , Médula Espinal/trasplante , Tretinoina/farmacología
2.
Healthc Inform Res ; 17(3): 190-5, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22084815

RESUMEN

OBJECTIVES: Factors such as an ageing and rapidly growing population, an increase in chronic disease rates and a global shortage of health professionals place increased pressure on Australian health departments to deliver more with less. To address the challenge faced by clinicians and support staff, the Queensland Department of Health established an eHealth strategy in 2006 with a vision to deliver a patient centric, networked model of care. METHODS: Queensland Health's eHealth program is a complex program which brings together the outputs and products of numerous projects to provide new clinical capabilities across the state. To ensure the potential benefits of the Queensland Government investment are realised, the eHealth program is implementing comprehensive benefits management to plan for key outcomes and benefits, support projects to deliver those benefits and ensure that they are delivered through ongoing measurement. RESULTS: The first stage of the eHealth program is already delivering benefits across the health department with a number of projects currently live in numerous sites across Queensland. CONCLUSIONS: By adopting an evidence based benefits management approach, Queensland Health's eHealth program is able to demonstrate the achievement of these benefits with tangible evidence that will create momentum for change in the short term, provide the evidence for future funding applications in the medium term, and build an understanding of the economic impacts of eHealth in the long term.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA